Skip to main content

Hectorol Disease Interactions

There are 2 disease interactions with Hectorol (doxercalciferol).

Major

Vitamin D analogs (applies to Hectorol) hypercalcemia

Major Potential Hazard, Moderate plausibility. Applicable conditions: Malabsorption Syndrome

Vitamin D analogs such as calciferol and ergocalciferol should not be given to patients with hypercalcemia, malabsorption syndrome, or evidence of vitamin D toxicity.

References

  1. (2001) "Product Information. Rocaltrol (calcitriol)." Roche Laboratories
  2. (2001) "Product Information. Zemplar (paricalcitol)." Abbott Pharmaceutical
  3. (2002) "Product Information. Delta D3 (cholecalciferol)." Freeda Vitamins Inc
  4. (2016) "Product Information. Drisdol (ergocalciferol)." sanofi-aventis
View all 4 references
Moderate

Vitamin D analogs (applies to Hectorol) hepatobiliary dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Biliary Obstruction

Vitamin D analogs are fat soluble and oral formulations require bile for adequate intestinal absorption. Hepatic and/or biliary dysfunction decrease the absorption of vitamin D analogs. Metabolites of vitamin D analogs are primarily excreted in bile and feces. Ergocalciferol, cholecalciferol, and dihydrotachysterol undergo hepatic hydroxylation during metabolic activation. Hepatic impairment can alter the metabolic and therapeutic activity of certain vitamin D analogs. Alternative vitamin D analogs such as calcifediol (requires renal activation) and calcitriol (active form) may be considered in patients with compromised hepatic function.

References

  1. (2001) "Product Information. Calciferol (ergocalciferol)." Schwarz Pharma
  2. (2001) "Product Information. Rocaltrol (calcitriol)." Roche Laboratories
  3. (2001) "Product Information. Calderol (calcifediol)." Organon

Hectorol drug interactions

There are 100 drug interactions with Hectorol (doxercalciferol).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer